UniSuper Management Pty Ltd Sells 10,165 Shares of McKesson Co. (NYSE:MCK)

UniSuper Management Pty Ltd trimmed its position in McKesson Co. (NYSE:MCK - Free Report) by 20.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 38,530 shares of the company's stock after selling 10,165 shares during the quarter. UniSuper Management Pty Ltd's holdings in McKesson were worth $21,959,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. FMR LLC raised its stake in shares of McKesson by 17.3% in the 3rd quarter. FMR LLC now owns 2,968,239 shares of the company's stock valued at $1,467,557,000 after buying an additional 438,423 shares in the last quarter. Geode Capital Management LLC increased its stake in McKesson by 1.0% in the third quarter. Geode Capital Management LLC now owns 2,653,288 shares of the company's stock valued at $1,306,873,000 after acquiring an additional 26,299 shares during the period. Boston Partners lifted its stake in McKesson by 24.6% during the fourth quarter. Boston Partners now owns 1,096,301 shares of the company's stock worth $625,501,000 after purchasing an additional 216,432 shares during the period. Nordea Investment Management AB boosted its holdings in McKesson by 20.0% during the fourth quarter. Nordea Investment Management AB now owns 975,935 shares of the company's stock valued at $558,606,000 after purchasing an additional 162,688 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec boosted its stake in shares of McKesson by 4.9% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 727,002 shares of the company's stock valued at $359,444,000 after purchasing an additional 34,262 shares in the last quarter. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Insider Transactions at McKesson

In other news, CEO Brian S. Tyler sold 8,961 shares of the stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the completion of the transaction, the chief executive officer now directly owns 60,664 shares in the company, valued at $36,276,465.36. This represents a 12.87 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Leann B. Smith sold 579 shares of McKesson stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total value of $331,645.41. Following the completion of the sale, the executive vice president now directly owns 864 shares in the company, valued at approximately $494,890.56. This represents a 40.12 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 18,689 shares of company stock valued at $11,187,351 in the last ninety days. 0.11% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several analysts have weighed in on MCK shares. StockNews.com lowered shares of McKesson from a "strong-buy" rating to a "buy" rating in a report on Friday, February 14th. Mizuho started coverage on McKesson in a research report on Wednesday, December 4th. They issued a "neutral" rating and a $630.00 price objective for the company. Morgan Stanley lifted their price objective on McKesson from $612.00 to $642.00 and gave the stock an "overweight" rating in a research report on Tuesday, December 17th. Wells Fargo & Company raised their price objective on shares of McKesson from $641.00 to $691.00 and gave the company an "equal weight" rating in a research note on Friday, March 14th. Finally, Evercore ISI lifted their price objective on McKesson from $650.00 to $675.00 and gave the stock an "outperform" rating in a research note on Thursday, February 6th. Two investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $649.36.

McKesson Price Performance

Shares of McKesson stock traded up $2.96 on Monday, hitting $671.02. The company had a trading volume of 254,998 shares, compared to its average volume of 835,024. McKesson Co. has a twelve month low of $464.42 and a twelve month high of $676.89. The stock has a 50-day moving average of $623.58 and a 200-day moving average of $579.83. The firm has a market capitalization of $84.10 billion, a P/E ratio of 30.69, a P/E/G ratio of 1.29 and a beta of 0.52.

McKesson (NYSE:MCK - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. Equities analysts predict that McKesson Co. will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be given a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a yield of 0.42%. The ex-dividend date is Monday, March 3rd. McKesson's dividend payout ratio (DPR) is currently 13.00%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.